Isotechnika Pharma Inc
Description Isotechnika Pharma Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of immunomodulating therapeutics. The companys lead drug, Voclosporin, is a calcineurin inhibitor that has completed Phase IIa and IIb clinical programs for use in organ transplantation and autoimmune diseases. It is also developing a portfolio of non-immunosuppressive cyclosporine analogue molecules with cyclophilin binding properties. Isotechnika Pharma Inc. was founded in 1993 and is headquartered in Edmonton, Canada. To view the detailed information, you need to SUBSCRIBE with us. |
 |